Express Pharma - Page 396 of 2181 - Express Pharma

Lupin receives US FDA approval for Dapagliflozin tablets

Inventia enters the U.S. market with FDA approved Dapagliflozin tablets

Biocon launches Bosaya and Aukelso in the United States

MSN Labs launches generic tablet Palborest for breast cancer treatment

Glenmark launches sacubitril+valsartan tablets in India to treat heart failure

Nutraceutical industry trends in 2023

HempStreet and MGC Pharma launch ArtemiC

NPPA revises ceiling prices of 128 medicines

USFDA gives tentative approval to Lupin’s Dolutegravir and Rilpivirine tablets

DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster dose

AbbVie and Eli Lilly exit UK drug pricing agreement

Eisai files for approval of Alzheimer’s drug in Japan

The Indian scenario of rare Lysosomal Storage Disorders, diagnostic and treatment approaches